Top Healthcare Technology Stocks To Buy Right Now

NEW YORK (TheStreet) -- Larry Summers has withdrawn his name as a potential candidate for Chairman of the Federal Reserve, even though he looked to be President Obama's man. Obama, despite all the negative baggage associated with this potential nominee, was likely to name him as the successor to Ben Bernanke.

This baggage included cozy Wall Street relationships, involvement with deregulation that led to much of the financial crisis and then his stepping down at Harvard due to his sexist remarks about women. Obama has already faced criticism from the female vote for his lack of appointments, especially painful since his 2012 Republican opponent Mitt Romney was seen as an enemy to female appointees.

Hot Dow Dividend Companies To Own In Right Now: Global Payments Inc.(GPN)

Global Payments Inc. provides electronic transaction processing services for merchants, independent sales organizations (ISO), financial institutions, government agencies, and multi-national corporations located in the United States, Canada, Europe, and the Asia-Pacific region. It offers a comprehensive line of processing solutions for credit and debit cards; business-to-business purchasing cards; gift cards; and electronic check conversion and check guarantee, verification, and recovery, including electronic check services, as well as terminal management. The company also offers proprietary software products to establish revolving check cashing limits for the casinos? customers in the gaming industry. In addition, it sells, installs, and services automated teller machine and point of sale terminals; and provides card issuing services, including card management and card personalization. The company markets its products directly, as well as through ISOs, retail outlets, tra de associations, alliance bank relationships, and financial institutions. Global Payments Inc. has a joint venture with La Caixa Group to provide merchant acquiring services to merchants in Spain. Global Payments Inc. was founded in 2001 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By Laura Brodbeck]

  Wednesday

  Earnings Expected From: Uniferst (NYSE: UNF), Constellation Brands (NYSE: STZ), RPM International (NYSE: RPM), Global Payments (NYSE: GPN) Economic Releases Expected: German trade balance, German factory orders, Australian retail sales

  Thursday

Top Healthcare Technology Stocks To Buy Right Now: Colonial Municipal Income Trust (CMU)

MFS High Yield Municipal Trust operates as a nondiversified, closed-end management investment company. The trust invests primarily in medium and lower quality bonds and notes issued by or on behalf of state and local government units. Its portfolio primarily comprises investments in health care, tax-backed, utilities, transportation, housing, education, industrials, resource recovery, industrial, manufacturing, oil and gas, and refunded/escrowed sectors. Columbia Management Advisors, Inc. serves as the investment advisor of the trust. The trust was formerly known as Colonial Municipal Income Trust and changed its name to MFS High Yield Municipal Trust in 2007. MFS High Yield Municipal Trust was founded in 1987 and is based in Boston, Massachusetts.

Advisors' Opinion:

• [By Paul McWilliams]

  Marvell (MRVL) is clearly carrying a big zit on its forehead from the ongoing legal battle with Carnigie Mellon University (CMU). A jury awarded CMU damages slightly in excess of $1B, and the judge could triple that.

Top Healthcare Technology Stocks To Buy Right Now: Eaton Corporation(ETN)

Eaton Corporation operates as a power management company worldwide. It provides electrical components and systems for power quality, distribution, and control; hydraulics components, systems, and services for industrial and mobile equipment; aerospace fuel, hydraulics, and pneumatic systems for commercial and military use; and truck and automotive drivetrain, and powertrain systems for performance, fuel economy, and safety. The company also manufactures screw-in cartridge valves, custom-engineered hydraulic valves, and manifold systems; and electrical and electromechanical systems. In addition, it designs, manufactures, and distributes intake and exhaust valves for diesel and gasoline engines; supplies electrical components for commercial and residential building applications and industrial controls for industrial equipment applications; and manufactures human machine interfaces, programmable logic controllers, and input/output devices. Further, the company also operates a s a provider of customized enclosures, rack systems, and air-flow management systems to store, power, and secure mission-critical IT data center electronics; and manufacturer, distributor, and service provider of single-phase and three-phase uninterruptible power supply systems. Eaton Corporation was founded in 1916 and is headquartered in Cleveland, Ohio.

Advisors' Opinion:

• [By Shauna O'Brien]

  On Monday, Morgan Stanley reported that it has raised its rating on power company Eaton Corporation (ETN).

  The firm has upgraded ETN from “Neutral” to “Overweight,” and has given the stock a $76 price target. This price target suggests a 12% increase from the stock’s current price of $66.79.

  Analysts expect to see EPS of $5 in 2014 and see favorable risk and reward.

  Eaton shares were up $1.12, or 1.71%, during Monday morning trading. The stock is up 23% YTD.

• [By Ron Rowland]

  Just rolled out, this new UBS exchange traded note (ETN) is targeted at investors desiring significant monthly income from a diversified multi-asset mix, notes Ron Rowland in Invest with an Edge.

Top Healthcare Technology Stocks To Buy Right Now: Illumina Inc.(ILMN)

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its instrumentation products include HiSeq 2000, an instrument for high-throughput (up to 200 Gb per run and up to 25 GB per day) sequencing using sequencing-by-synthesis (SBS) technology; Genome Analyzer IIx, an instrument for medium to high-throughput (up to 95 Gb per run) sequencing using SBS technology; Genome Analyzer IIe, an instrument for low to medium throughput (up to 40 Gb per run) sequencing using SBS technology; iScan System, a high-resolution imaging instrument to scan BeadArray based assays; and BeadXpress Reader, a low- to mid-multiplex, high-throughput instrument for readout of assays. The company?s consumables consist of InfiniumHD Whole-Genome BeadChips comprising HumanOmniExpress, HumanOmni1-Quad, Human1M-Duo, and BovineHD, which are multi-sample DNA analysis microarrays; iSelect Custom Genotyping BeadChips that are custome r designable SNP genotyping arrays; GoldenGate Assay Method, a high throughput assay and genotyping system; GoldenGate Universal-32 Sample BeadChip, which are 32 sample GoldenGate genotyping arrays; Paired-End Genomic DNA Sample Prep Kit, a streamlined library preparation kit to generate 200?500 kb insert paired-end reads; VeraCode GoldenGate that are low plex GoldenGate genotyping arrays compatible with the BeadXpress System; Standard Sequencing Kit, reagents used for SBS chemistry on sequencing platforms; and Infinium Assay Kit, reagents used to perform Infinium assays on the iScan platform. It also provides sequencing and genotyping services. The company?s customers include pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products companies, as well as research centers. It sells its products through distributors in North America, Europe, the Asia-Pacific, the Middle East, and South Africa. Illumina was founded in 1998 and is headquartered in San Dieg o, California.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  Illumina, Inc. (Nasdaq: ILMN) is a groundbreaking company with a unique focus on using genetics for medical care and is a leader in the budding field of personalized medicine.

• [By Vanina Egea]

  Illumina Inc. (ILMN) is a leading developer and distributor of next-generation integrated systems used for the large-scale analysis of genetic variation and function. It applies innovative DNA sequencing as well as an array of technologies to provide information that could be used to improve drugs and therapies, customize diagnostics and treatments, and cure diseases. The firm is developing a wide line of products that "can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine."